The DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.
Tumor Dormancy Induced by Downregulation of Urokinase Receptor in Human Carcinoma Involves Integrin and MAPK Signaling
Open accessAbstract
Mechanisms that regulate the transition of metastases from clinically undetectable and dormant to progressively growing are the least understood aspects of cancer biology. Here, we show that a large (∼70%) reduction in the urokinase plasminogen activator receptor (uPAR) level in human carcinoma HEp3 cells, while not affecting their in vitro growth, induced a protracted state of tumor dormancy in vivo, with G0/G1 arrest. We have now identified the mechanism responsible for the induction of dormancy. We found that uPA/uPAR proteins were physically associated with α5β1, and that in cells with low uPAR the frequency of this association was significantly reduced, leading to a reduced avidity of α5β1 and a lower adhesion of cells to the fibronectin (FN). Adhesion to FN resulted in a robust and persistent ERK1/2 activation and serum-independent growth stimulation of only uPAR-rich cells. Compared with uPAR-rich tumorigenic cells, the basal level of active extracellular regulated kinase (ERK) was four to sixfold reduced in uPAR-poor dormant cells and its stimulation by single chain uPA (scuPA) was weak and showed slow kinetics. The high basal level of active ERK in uPAR-rich cells could be strongly and rapidly stimulated by scuPA. Disruption of uPAR–α5β1 complexes in uPAR-rich cells with antibodies or a peptide that disrupts uPAR–β1 interactions, reduced the FN-dependent ERK1/2 activation. These results indicate that dormancy of low uPAR cells may be the consequence of insufficient uPA/uPAR/α5β1 complexes, which cannot induce ERK1/2 activity above a threshold needed to sustain tumor growth in vivo. In support of this conclusion we found that treatment of uPAR-rich cells, which maintain high ERK activity in vivo, with reagents interfering with the uPAR/β1 signal to ERK activation, mimic the in vivo dormancy induced by downregulation of uPAR.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Angiogenesis in cancer, vascular, rheumatoid and other disease
Folkman, J. (1995) · Nature Medicine · doi:10.1038/nm0195-27 · Cited by 7,627
O'Reilly, M. (1994) · Cell · doi:10.1016/0092-8674(94)90200-3 · Cited by 3,345
The urokinase-type plasminogen activator system in cancer metastasis: A review
Andreasen, P. A., Kjøller, L., Christensen, L., & Duffy, M. J. (1997) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19970703)72:1<1::aid-ijc1>3.0.co;2-z · Cited by 1,546
Biology and biochemistry of proteinases in tumor invasion
Mignatti, P., & Rifkin, D. B. (1993) · Physiological Reviews · doi:10.1152/physrev.1993.73.1.161 · Cited by 1,244
Werb, Z., Tremble, P. M., Behrendtsen, O., Crowley, E., & Damsky, C. H. (1989) · The Journal of cell biology · doi:10.1083/jcb.109.2.877 · Cited by 1,059
Miyamoto, S., Teramoto, H., Gutkind, J. S., & Yamada, K. M. (1996) · The Journal of cell biology · doi:10.1083/jcb.135.6.1633 · Cited by 760
The Adaptor Protein Shc Couples a Class of Integrins to the Control of Cell Cycle Progression
Wary, K. K., Mainiero, F., Isakoff, S. J., Marcantonio, E. E., & Giancotti, F. G. (1996) · Cell · doi:10.1016/s0092-8674(00)81392-6 · Cited by 731
Regulation of Integrin Function by the Urokinase Receptor
Wei, Y., Lukashev, M., Simon, D. I., Bodary, S. C., Rosenberg, S., Doyle, M. V., & Chapman, H. A. (1996) · Science · doi:10.1126/science.273.5281.1551 · Cited by 727
Wary, K. K., Mariotti, A., Zurzolo, C., & Giancotti, F. G. (1998) · Cell · doi:10.1016/s0092-8674(00)81604-9 · Cited by 718
Wang, F., Weaver, V. M., Petersen, O. W., Larabell, C. A., Dedhar, S., Briand, P., Lupu, R., & Bissell, M. J. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.25.14821 · Cited by 653
Molecular interactions in cell adhesion complexes
Yamada, K. (1997) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(97)80155-x · Cited by 584
Ploug, M., Rønne, E., Behrendt, N., Jensen, A. L., Blasi, F., & Danø, K. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)52382-6 · Cited by 574
Dong, Z., Kumar, R., Yang, X., & Fidler, I. J. (1997) · Cell · doi:10.1016/s0092-8674(00)81926-1 · Cited by 525
Damsky, C. H., & Werb, Z. (1992) · Current Opinion in Cell Biology · doi:10.1016/0955-0674(92)90100-q · Cited by 518
Kim, J., Yu, W., Kovalski, K., & Ossowski, L. (1998) · Cell · doi:10.1016/s0092-8674(00)81478-6 · Cited by 468
Self-citationPlasminogen activators, integrins, and the coordinated regulation of cell adhesion and migration
Chapman, H. A. (1997) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(97)80126-3 · Cited by 464
A Role for Caveolin and the Urokinase Receptor in Integrin-mediated Adhesion and Signaling
Wei, Y., Yang, X., Liu, Q., Wilkins, J. A., & Chapman, H. A. (1999) · The Journal of Cell Biology · doi:10.1083/jcb.144.6.1285 · Cited by 392
Regulation of the Cell Cycle by Focal Adhesion Kinase
Zhao, J.-H., Reiske, H., & Guan, J.-L. (1998) · The Journal of Cell Biology · doi:10.1083/jcb.143.7.1997 · Cited by 347
Bohuslav, J., Horejsí, V, Hansmann, C., Stöckl, J., Weidle, U. H., Majdic, O., Bartke, I., Knapp, W., & Stockinger, H. (1995) · The Journal of experimental medicine · doi:10.1084/jem.181.4.1381 · Cited by 345
Mainiero, F., Murgia, C., Wary, K. K., Curatola, A. M., Pepe, A., Blumemberg, M., Westwick, J. K., Der, C. J., & Giancotti, F. G. (1997) · The EMBO Journal · doi:10.1093/emboj/16.9.2365 · Cited by 326
Constitutive activation of mitogen-activated protein (MAP) kinases in human renal cell carcinoma.
Oka, H., Chatani, Y., Hoshino, R., Ogawa, O., Kakehi, Y., Terachi, T., Okada, Y., Kawaichi, M., Kohno, M., & Yoshida, O. (1995) · PubMed · Cited by 299
Wu, C., Keightley, S. Y., Leung-Hagesteijn, C., Radeva, G., Coppolino, M., Goicoechea, S., McDonald, J. A., & Dedhar, S. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.1.528 · Cited by 281
Urokinase Receptor (CD87) Regulates Leukocyte Recruitment via β2 Integrins In Vivo
May, A. E., Kanse, S. M., Lund, L. R., Gisler, R. H., Imhof, B. A., & Preissner, K. T. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.6.1029 · Cited by 270
Busso, N., Masur, S. K., Lazega, D., Waxman, S., & Ossowski, L. (1994) · The Journal of Cell Biology · doi:10.1083/jcb.126.1.259 · Cited by 263
Self-citationOverexpression of the Integrin-linked Kinase Promotes Anchorage-independent Cell Cycle Progression
Radeva, G., Petrocelli, T., Behrend, E., Leung-Hagesteijn, C., Filmus, J., Slingerland, J., & Dedhar, S. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.21.13937 · Cited by 257
Varner, J. A., Emerson, D. A., & Juliano, R. L. (1995) · Molecular Biology of the Cell · doi:10.1091/mbc.6.6.725 · Cited by 245
Lin, T. H., Aplin, A. E., Shen, Y., Chen, Q., Schaller, M., Romer, L., Aukhil, I., & Juliano, R. L. (1997) · The Journal of Cell Biology · doi:10.1083/jcb.136.6.1385 · Cited by 245
Fazioli, F. (1997) · The EMBO Journal · doi:10.1093/emboj/16.24.7279 · Cited by 238
Structural requirements for the growth factor activity of the amino-terminal domain of urokinase.
Rabbani, S. A., Mazar, A. P., Bernier, S. M., Haq, M., Bolivar, I., Henkin, J., & Goltzman, D. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)49691-9 · Cited by 234
Toolan, H. W. (1954) · PubMed · Cited by 231
Integrins take partners: cross-talk between integrins and other membrane receptors
Porter, J. C., & Hogg, N. (1998) · Trends in Cell Biology · doi:10.1016/s0962-8924(98)01344-0 · Cited by 227
Xue, W., Mizukami, I. F., Todd, R. F., & Petty, H. R. (1997) · PubMed · Cited by 221
In vivo paracrine interaction between urokinase and its receptor: effect on tumor cell invasion.
Ossowski, L., Clunie, G., Masucci, M. T., & Blasi, F. (1991) · The Journal of cell biology · doi:10.1083/jcb.115.4.1107 · Cited by 206
Self-citationNguyen, D. H. D., Hussaini, I. M., & Gonias, S. L. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.14.8502 · Cited by 205
Murgia, C., Blaikie, P., Kim, N., Dans, M., Petrie, H. T., & Giancotti, F. G. (1998) · The EMBO Journal · doi:10.1093/emboj/17.14.3940 · Cited by 199
Sier, C. F. M., Stephens, R. W., Bízik, J., Mariani, A., Bassan, M., Pedersen, N. M., Frigerio, L., Ferrari, A. G., Danø, K., Brünner, N., et al. (1998) · PubMed · Cited by 191
Rønne, E., Behrendt, N., Ellis, V., Ploug, M., Danø, K., & Høyer-Hansen, G. (1991) · FEBS Letters · doi:10.1016/0014-5793(91)81042-7 · Cited by 186
Xue, W., Kindzelskii, A. L., Todd, R. F., & Petty, H. R. (1994) · The Journal of Immunology · doi:10.4049/jimmunol.152.9.4630 · Cited by 185
Kook, Y. H., Adamski, J., Zelent, A., & Ossowski, L. (1994) · The EMBO Journal · doi:10.1002/j.1460-2075.1994.tb06714.x · Cited by 166
Self-citationTang, H., Kerins, D. M., Hao, Q., Inagami, T., & Vaughan, D. E. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.29.18268 · Cited by 159
Reduction in Surface Urokinase Receptor Forces Malignant Cells into a Protracted State of Dormancy
Yu, W., Kim, J., & Ossowski, L. (1997) · The Journal of Cell Biology · doi:10.1083/jcb.137.3.767 · Cited by 155
Self-citationProliferation of a human epidermal tumor cell line stimulated by urokinase
Kirchheimer, J. C., Wojta, J., Christ, G., & Binder, B. R. (1987) · The FASEB Journal · doi:10.1096/fasebj.1.2.3038646 · Cited by 129
Downstream targets of urokinase‐type plasminogen‐activator‐mediated signal transduction
Konakova, M., Hucho, F., & Schleuning, W.-D. D. (1998) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.1998.2530421.x · Cited by 104
Changes in malignant phenotype of a human carcinoma conditioned by growth environment
Ossowski, L., & Reich, E. (1983) · Cell · doi:10.1016/0092-8674(83)90414-2 · Cited by 102
Self-citationBazzoni, G., Ma, L., Blue, M., & Hemler, M. E. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.12.6670 · Cited by 92
Mortarini, R., Gismondi, A., Santoni, A., Parmiani, G., & Anichini, A. (1992) · PubMed · Cited by 59
Marcheş, R., Scheuermann, R. H., & Uhr, J. W. (1998) · PubMed · Cited by 34
Schiller, J. H., & BITTNER, G. (1995) · PubMed · Cited by 31
Cited by
Emerging Biological Principles of Metastasis
Lambert, A. W., Pattabiraman, D. R., & Weinberg, R. A. (2017) · Cell · doi:10.1016/j.cell.2016.11.037 · Cited by 3,067
Models, mechanisms and clinical evidence for cancer dormancy
Aguirre-Ghiso, J. A. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2256 · Cited by 1,677
Neutrophil extracellular traps produced during inflammation awaken dormant cancer cells in mice
Albrengues, J., Shields, M. A., Ng, D., Park, C. G., Ambrico, A., Poindexter, M. E., Upadhyay, P., Uyeminami, D. L., Pommier, A., Küttner, V., et al. (2018) · Science · doi:10.1126/science.aao4227 · Cited by 1,476
uPAR: a versatile signalling orchestrator
Blasi, F., & Carmeliet, P. (2002) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm977 · Cited by 1,223
Regulation of cell signalling by uPAR
Smith, H. W., & Marshall, C. J. (2010) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2821 · Cited by 960
Metadata
- Authors
- Ghiso, J. A. A., Kovalski, K., & Ossowski, L.
- Venue
- The Journal of Cell Biology
- Publisher
- Rockefeller University Press
- Published
- 1999-10-04
- Volume
- 147
- Issue
- 1
- Pages
- 89-104
- ISSN
- 0021-9525 (ISSN-L)
- 1540-8140
- OpenAlex
- W2171774285
- Cited by
- 549
- References
- 48
- FWCI
- 6.87
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.